Annelize Koch

Neural and Behavioral Effects of a Novel Mu Opioid Receptor Antagonist in Binge-Eating Obese People

Victoria C. Cambridge, Hisham Ziauddeen, Pradeep J. Nathan et al. · Biological Psychiatry · 2012 · 92 citations · Full text

Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluria

Bernd Höppe, Annelize Koch, Pierre Cochat et al. · Kidney International · 2021 · 87 citations · Full text

Evaluation of the safety profile of an electronic vapour product used for two years by smokers in a real-life setting

Tanvir Walele, Jim Bush, Annelize Koch et al. · Regulatory Toxicology and Pharmacology · 2017 · 69 citations · Full text

Asthma, Tobacco Cessation, Electronic Vapour Product +22

The effects of the dopamine D3 receptor antagonist GSK598809 on attentional bias to palatable food cues in overweight and obese subjects

Pradeep J. Nathan, Barry V. O’Neill, Karin Mogg et al. · The International Journal of Neuropsychopharmacology · 2011 · 60 citations

Opioid Receptor Modulation of Hedonic Taste Preference and Food Intake: A Single‐Dose Safety, Pharmacokinetic, and Pharmacodynamic Investigation With GSK1521498, a Novel μ‐Opioid Receptor Inverse Agonist

Pradeep J. Nathan, Barry V. O’Neill, Mark Bush et al. · The Journal of Clinical Pharmacology · 2011 · 49 citations